General Info
Boryung Pharmaceutical operates within the healthcare sector and is engaged in the manufacturing and marketing of pharmaceutical products.
Location: Seoul
Country:
Industries:
Investment Regions: SEA
Investment Stages: late-stage, seed, series-a
Website: http://www.boryung.co.kr/
corporate-vc
SEA
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: active
AI Reasoning: I found a news article reporting that Boryung Pharmaceutical invested in ExoRenal with a disclosed investment (6 billion won) and the article date is October 5, 2024. Counting from that date to November 1, 2025, the last known investment occurred more than 12 months ago but less than 13 months, specifically about 12 months and 27 days ago. That places the last known investment in the >12 months category. However, classification ranges: not-active (>12 months), low-active (12-6 months), active (6-3 months), very-active (<3 months). Because the last known investment was just over 12 months ago, the correct tag is not-active.[/evc_normalize]
Here are the thresholds established for the different statuses:
Not Active – No known investments in the last 12 months.
Low Activity – Only known investments between the last 12 and 6 months.
Active – Known investments between the last 6 and 3 months.
Very Active – Known investments in the last 3 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Warm Intros from Portfolio Companies
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Boryung Pharmaceutical

Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI
